NTNG1 Modulates Cisplatin Resistance in Epithelial Ovarian Cancer Cells via the GAS6/AXL/Akt Pathway

Cisplatin resistance is a challenge in the treatment of epithelial ovarian cancer. Here, clinical data showed that the level of netrin-G1 (NTNG1) in cisplatin-resistant cancer was higher than that in cisplatin-sensitive cancer (2.2-fold, p = 0.005); patients with a high NTNG1 level in cancer tissues...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Shanyu, Luo, Yuanyuan, Zhang, Ying, Wang, Houmei, Liu, Qianfen, Li, Xinya, Yu, Tinghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281315/
https://www.ncbi.nlm.nih.gov/pubmed/34277602
http://dx.doi.org/10.3389/fcell.2021.652325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281315/
https://www.ncbi.nlm.nih.gov/pubmed/34277602
http://dx.doi.org/10.3389/fcell.2021.652325

Ejemplares similares